Exabis Library
Welcome to the e-CCO Library!
P518: Remission induction in corticosteroid naïve children and adolescents with ulcerative colitis by adsorptive leucocytapheresis as monotherapy or in combination with low dose prednisolone after failure of first-line medications
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P518: Safety of upadacitinib in ulcerative colitis: Long-term data from the phase 3 open-label extension study (U-ACTIVATE)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P518: Vedolizumab trough concentrations are associated with endoscopic response in patients with inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P519 Higher anti-TNF α trough levels are not associated with increased radiological response in perianal fistulising Crohn’s disease: A multicentre study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P519: Analysis of the effectiveness and safety of switching from originator to biosimilar adalimumab in patients with Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P519: Anti-tumour necrosis-alpha therapy during pregnancy in patients with inflammatory bowel disease: safety in women and children
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P519: Impact of skin examination prior to initiation of biological treatment in patients with Inflammatory Bowel Disease: preliminary data
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P519: Mirikizumab pharmacokinetics and exposure-response relationships in patients with moderately to severely active ulcerative colitis: results from randomised phase 2 and phase 3 induction and maintenance trials
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P519: Post-surgical recurrence predictors in the years 2000. Results of a retrospective single-centre long-term follow-up series and impact of imaging findings on outcomes
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P519: Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: Multicentre study at 12 months results
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P520 Association between ustekinumab trough levels and biomarkers in patients with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P520: Endoscopic evaluation and factors affecting the endoscopic efficacy during granulomonocytapheresis in moderately-to-severely active ulcerative colitis: a multi-centre retrospective study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P520: Gastrointestinal ultrasonography in pregnant patients with IBD is useful in the identification of active intestinal inflammation
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P520: Perspective and self-efficacy of adolescents with inflammatory bowel disease post transition to adult care
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P520: Thromboembolic and major adverse cardiovascular events among patients in the filgotinib clinical trial programme
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P520: Very early intestinal ultrasound predicts intravenous corticosteroid failure in hospitalized severe ulcerative colitis patients
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P520: ‘Eetscore’ in patients with Inflammatory Bowel Disease: an online tool to assess diet quality and provide personalised dietary advice
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P521 Infection of the anal canal by human papillomavirus in Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P521: A prospective cohort study to assess the relevance of Vedolizumab drug level monitoring in IBD patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P521: Correlation between physician disease assessment in Ulcerative Colitis and burden of disease: ICONIC 2-year data of 120 patients in Turkey
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM